Suppr超能文献

阿片类药物治疗的风险:来自安全网诊所的初级保健从业者和患者的观点。

The risks of opioid treatment: Perspectives of primary care practitioners and patients from safety-net clinics.

作者信息

Hurstak Emily E, Kushel Margot, Chang Jamie, Ceasar Rachel, Zamora Kara, Miaskowski Christine, Knight Kelly

机构信息

a Department of Medicine , University of California San Francisco , San Francisco , California , USA.

b Division of General Internal Medicine , University of California San Francisco/Zuckerberg San Francisco General Hospital , San Francisco , California , USA.

出版信息

Subst Abus. 2017 Apr-Jun;38(2):213-221. doi: 10.1080/08897077.2017.1296524. Epub 2017 Apr 10.

Abstract

BACKGROUND

Patients with a history of substance use are more likely than those without substance use to experience chronic noncancer pain (CNCP), to be prescribed opioids, and to experience opioid misuse or overdose. Primary care practitioners (PCPs) in safety-net settings care for low-income patients with CNCP and substance use, usually without specialist consultation. To inform communication related to opioid risk, we explored PCPs' and patients' perceptions of the risks of chronic opioid therapy.

METHODS

We conducted semistructured interviews with 23 PCPs and 46 of their patients, who had a history of CNCP and substance use. We recruited from 6 safety-net health care settings in the San Francisco Bay Area. We transcribed interviews verbatim and analyzed transcripts using grounded theory methodology.

RESULTS

(1) PCPs feared harming patients and the community by opioid prescribing. PCPs emphasized fear of opioid overdose. (2) Patients did not highlight concerns about the adverse health consequences of opioids, except for addiction. (3) Both patients and PCPs were concerned about PCPs' medicolegal risks related to opioid prescribing. (4) Patients reported feeling stigmatized by policies aimed at reducing opioid misuse.

CONCLUSION

We identified differences in how clinicians and patients perceive opioid risk. To improve the informed consent process for opioid therapy, patients and PCPs need to have a shared understanding of the risks of opioids and engage in discussions that promote patient autonomy and safety. As clinics implement opioid prescribing policies, clinicians must develop effective communication strategies in order to educate patients about opioid risks and decrease patients' experiences of stigma and discrimination.

摘要

背景

有物质使用史的患者比无物质使用史的患者更有可能经历慢性非癌性疼痛(CNCP)、被开具阿片类药物处方以及出现阿片类药物滥用或过量情况。安全网环境中的初级保健医生(PCP)为患有CNCP和物质使用问题的低收入患者提供护理,通常无需专科医生会诊。为了为与阿片类药物风险相关的沟通提供信息,我们探讨了初级保健医生和患者对慢性阿片类药物治疗风险的认知。

方法

我们对23名初级保健医生及其46名有CNCP和物质使用史的患者进行了半结构化访谈。我们从旧金山湾区的6个安全网医疗保健机构招募了参与者。我们逐字转录访谈内容,并使用扎根理论方法分析转录本。

结果

(1)初级保健医生担心开具阿片类药物会对患者和社区造成伤害。初级保健医生强调担心阿片类药物过量。(2)患者除了对成瘾问题外,没有突出对阿片类药物不良健康后果的担忧。(3)患者和初级保健医生都担心初级保健医生在开具阿片类药物方面的法医学风险。(4)患者报告称,旨在减少阿片类药物滥用的政策让他们感到受到了污名化。

结论

我们发现临床医生和患者在如何看待阿片类药物风险方面存在差异。为了改善阿片类药物治疗的知情同意过程,患者和初级保健医生需要对阿片类药物的风险有共同的理解,并参与促进患者自主性和安全性的讨论。随着诊所实施阿片类药物处方政策,临床医生必须制定有效的沟通策略,以便向患者宣传阿片类药物风险,并减少患者的污名化和歧视经历。

相似文献

1
The risks of opioid treatment: Perspectives of primary care practitioners and patients from safety-net clinics.
Subst Abus. 2017 Apr-Jun;38(2):213-221. doi: 10.1080/08897077.2017.1296524. Epub 2017 Apr 10.
2
Sources and Impact of Time Pressure on Opioid Management in the Safety-Net.
J Am Board Fam Med. 2019 May-Jun;32(3):375-382. doi: 10.3122/jabfm.2019.03.180306.
5
Patient and provider characteristics associated with communication about opioids: An observational study.
Patient Educ Couns. 2019 May;102(5):888-894. doi: 10.1016/j.pec.2018.12.005. Epub 2018 Dec 3.
6
Primary care providers' views on chronic pain management among high-risk patients in safety net settings.
Pain Med. 2012 Sep;13(9):1141-8. doi: 10.1111/j.1526-4637.2012.01443.x. Epub 2012 Jul 30.
7
9
Patients' and clinicians' perspectives of co-use of cannabis and opioids for chronic non-cancer pain management in primary care.
Int J Drug Policy. 2019 Jan;63:23-28. doi: 10.1016/j.drugpo.2018.09.002. Epub 2018 Nov 23.

引用本文的文献

2
Group-Based Integrative Pain Management in Primary Care: A Study Protocol for Multilevel Interventions to Address Health Disparities.
Glob Adv Integr Med Health. 2024 Nov 19;13:27536130241302043. doi: 10.1177/27536130241302043. eCollection 2024 Jan-Dec.
4
First-hand accounts of structural stigma toward people who use opioids on Reddit.
Soc Sci Med. 2024 Apr;347:116772. doi: 10.1016/j.socscimed.2024.116772. Epub 2024 Mar 16.
5
Telehealth for management of chronic non-cancer pain and opioid use disorder in safety net primary care.
BMC Health Serv Res. 2023 Apr 1;23(1):325. doi: 10.1186/s12913-023-09330-w.
8
The relationship between patients' income and education and their access to pharmacological chronic pain management: A scoping review.
Can J Pain. 2022 Sep 1;6(1):142-170. doi: 10.1080/24740527.2022.2104699. eCollection 2022.
9
In Their Own Words: How Opioids Have Impacted the Lives of "Everyday" People Living in Appalachia.
J Appalach Health. 2020 Sep 1;2(4):26-36. doi: 10.13023/jah.0204.05. eCollection 2020.
10
Factors Associated with Pain Treatment Satisfaction Among Patients with Chronic Non-Cancer Pain and Substance Use.
J Am Board Fam Med. 2021 Nov-Dec;34(6):1082-1095. doi: 10.3122/jabfm.2021.06.210214.

本文引用的文献

1
Understanding Risk Factors for Opioid Overdose in Clinical Populations to Inform Treatment and Policy.
J Addict Med. 2016 Nov/Dec;10(6):369-381. doi: 10.1097/ADM.0000000000000245.
2
CDC Guideline for Prescribing Opioids for Chronic Pain - United States, 2016.
MMWR Recomm Rep. 2016 Mar 18;65(1):1-49. doi: 10.15585/mmwr.rr6501e1.
3
Primary care experiences of people who live with chronic pain and receive opioids to manage pain: A qualitative methodology.
J Am Assoc Nurse Pract. 2016 Aug;28(8):429-35. doi: 10.1002/2327-6924.12342. Epub 2016 Jan 22.
4
Increases in Drug and Opioid Overdose Deaths--United States, 2000-2014.
MMWR Morb Mortal Wkly Rep. 2016 Jan 1;64(50-51):1378-82. doi: 10.15585/mmwr.mm6450a3.
5
Distribution of Opioids by Different Types of Medicare Prescribers.
JAMA Intern Med. 2016 Feb;176(2):259-61. doi: 10.1001/jamainternmed.2015.6662.
9
Effect of Florida's Prescription Drug Monitoring Program and Pill Mill Laws on Opioid Prescribing and Use.
JAMA Intern Med. 2015 Oct;175(10):1642-9. doi: 10.1001/jamainternmed.2015.3931.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验